Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
CAS: 195062-62-5
Rif. 3D-VHA06262
1g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
25g | Fuori produzione | ||
50g | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)benzoic acid ethyl ester
- 4-Carboethoxyphenylboronic Acid Pinacol Ester
- 4-Ethoxycarbonylphenylboronic Acid, Pinacol Ester
- Benzoic acid, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, ethyl ester
- Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
- 2-(4-(Ethoxycarbonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
- Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate is a boron based mimetic that inhibits the transcriptional coactivator activity of benzodiazepine. It binds to the amino group of the coactivator domain and prevents the coactivator from binding to DNA. This mimetic also has inhibitory activity against other benzodiazepine derivatives such as transactivation and interactions with protein kinase C. Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate can be used as a research tool for investigating benzodiazepine receptor activation.